Development Level

Tclin 3 | 602
Tbio 1 | 10,625

Disease

Diabetes mellitus type 2 3 | 69
Lactic acidosis 3 | 43
Leber hereditary optic neuropathy 3 | 17
Leber's optic atrophy 3 | 10
Leigh disease 3 | 81
Leigh syndrome 3 | 34
MELAS syndrome 3 | 17
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes 3 | 9
Mitochondrial complex I deficiency 3 | 37
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome 3 | 5
Mitochondrial myopathy 3 | 24
Optic Atrophy, Hereditary, Leber 3 | 14
Treatment Refractory Type 2 Diabetes Mellitus 3 | 53
Dystonia 2 | 77
LEBER OPTIC ATROPHY AND DYSTONIA 2 | 4
LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY 2 | 14
Leber hereditary optic neuropathy with dystonia 2 | 2
Neuropathy 2 | 210
Optic Atrophies, Hereditary 2 | 2
Parkinson Disease 6, Autosomal Recessive Early-Onset 2 | 3
Retinitis pigmentosa 2 | 156
Wolff-Parkinson-White syndrome 2 | 11
Acute coronary syndrome 1 | 37
Adenocarcinoma 1 | 115
Amblyopia 1 | 24
Arthritis 1 | 248
Atherosclerosis 1 | 275
Behcet's disease 1 | 74
Blindness 1 | 84
Brucellosis 1 | 24
Cancer 1 | 2,346
Cardiomyopathies 1 | 90
Carrion's Disease 1 | 6
Chancroid 1 | 8
Chlamydia 1 | 18
Colon neuroendocrine neoplasm 1 | 1
Coronary artery disease 1 | 240
Deafness, Aminoglycoside-Induced 1 | 4
Ehrlichiosis 1 | 9
Endocarditis 1 | 18
Endotoxemia 1 | 8
Gastritis 1 | 44
HIV Infections 1 | 100
Hypersensitivity reaction type II disease 1 | 235
Hypertrophic Cardiomyopathy 1 | 56
Infarction, Middle Cerebral Artery 1 | 25
Infertility 1 | 163
Leprosy 1 | 77
Leukodystrophy 1 | 30
Leukodystrophy, hypomyelinating, 4 1 | 1
Lown-Ganong-Levine syndrome 1 | 3
Lymphadenitis 1 | 12
MERRF syndrome 1 | 5
Malaria 1 | 140
Melioidosis 1 | 11
Mitochondrial Complex 1 Deficiency 1 | 28
Multiple Sclerosis 1 | 498
Myiasis 1 | 8
Myoclonus with epilepsy with ragged red fibers 1 | 1
Neurodegenerative disease 1 | 383
Nocardiosis 1 | 4
Optic atrophy 1 | 43
Paraplegia 1 | 71
Pearson syndrome 1 | 17
Pelvic inflammatory disease 1 | 21
Renal Cell Carcinoma 1 | 199
Schizophrenia 1 | 503
Scotoma 1 | 7
Scrub typhus 1 | 7
Sennetsu fever 1 | 2
Spastic paraplegia 13, autosomal dominant 1 | 1
Spotted fever 1 | 7
Stomach Neoplasms 1 | 282
Tetanus 1 | 66
Tularemia 1 | 22
Wolfram syndrome 1 | 11
cat-scratch disease 1 | 9
diabetes mellitus 1 | 1,663
ependymoma 1 | 2,514
hereditary spastic paraplegia 1 | 313
oligodendroglioma 1 | 2,849
osteosarcoma 1 | 7,933
ovarian cancer 1 | 8,492
periodontitis 1 | 269
sonic hedgehog group medulloblastoma 1 | 1,482
tuberculosis 1 | 1,563
tuberculosis and treatment for 3 months 1 | 327

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Enzyme 3 | 4,146
Non-IDG 1 | 11,969

Grant Application

5R01GM109434-02 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
NADH-ubiquinone oxidoreductase chain 4 MT-ND4 Tclin Enzyme -3.01595 1026.1 6
NADH-ubiquinone oxidoreductase chain 6 MT-ND6 Tclin Enzyme -2.78772 585.6 62
NADH-ubiquinone oxidoreductase chain 5 MT-ND5 Tclin Enzyme -2.72771 504.3 159
60 kDa heat shock protein, mitochondrial HSPD1 Tbio Non-IDG -3.54151 3756.0 1112